AGA Institute presents cutting-edge research ...( Chicago IL (May 29 2009) Clinicians...),Health

Chicago, IL (May 29, 2009) Clinicians, researchers and scientists from around the world will gather for Digestive Disease Week 2009 (DDW), the largest and most prestigious gastroenterology meeting, from May 30 to June 4, 2009, at the McCormick Place Convention Center, Chicago, IL. DDW is the annual meeting of the American Gastroenterological Association (AGA) Institute, the largest and oldest GI society in the world. AGA Institute researchers will present exciting, cutting-edge data during the meeting that will help change the way physicians diagnose and treat GI disorders.

Please note that all data presented during DDW is embargoed until the beginning of the presentation or an official DDW press conference, whichever occurs first. Go to www.ddw.org for a list of press conferences.

On Tuesday, June 2 from 2:15 - 3:45 p.m. CDT, Room E451B, the AGA Institute will feature its late-breaking clinical abstracts, which include exciting data on:

• OPT-80 versus vancomycin in Clostridium difficile infection: Results of a randomized clinical trial. M. Miller et al. (2:15 p.m.)
• Phase II Efficacy of Human Monoclonal Antibody Treatment to prevent C. difficile Recurrence. I. Lowy et al. (2:30 p.m.)*
• Effectiveness of the Third Eye Retroscope for Detecting Polyps in the Right Colon. J.D. Waye et al. (2:45 p.m.)
• SVR Results of PROVE3, a Phase 2b Clinical Trial Assessing Safety and Efficacy of Telaprevir in Hepatitis C Genotype-1-Infected Patients with Prior Non-response, Viral Breakthrough or Relapse to Peginterferon-Alfa-2a/b and Ribavirin Therapy. A.M. Di Bisceglie et al. (3:00 p.m.)*
• Adalimumab Induces and Maintains Mucosal Healing in Patients With Moderate to Severe Ileocolonic Crohn's Disease First Results of the EXTEND Trial. P. Rutgeerts, et al. (3:15 p.m.)
• One Year Data from the SONIC Study: A Randomized, Double-Blind Tria
  '/>"/>